{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T00:57:14Z","timestamp":1794272234040,"version":"4.9.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T00:00:00Z","timestamp":1737331200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","annallergy.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma & Immunology"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.anai.2025.01.003","type":"journal-article","created":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T02:05:54Z","timestamp":1737079554000},"page":"548-555.e4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Small airway dysfunction mediates the relationship between Fractional Exhaled Nitric Oxide and asthma control"],"prefix":"10.1016","volume":"134","author":[{"given":"Marcello","family":"Cottini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Ventura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Lombardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Landi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Imeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiano","family":"Di Marco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale","family":"Comberiati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvise","family":"Berti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.anai.2025.01.003_bib0001","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1136\/thorax-2023-221329","article-title":"Type-2 inflammation: a key treatable trait associated with lung function decline in chronic airways disease","volume":"79","author":"Petousi","year":"2024","journal-title":"Thorax"},{"issue":"5","key":"10.1016\/j.anai.2025.01.003_bib0002","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1164\/rccm.9120-11ST","article-title":"An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications","volume":"184","author":"Dweik","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"10.1016\/j.anai.2025.01.003_bib0003","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1164\/rccm.200406-710ST","article-title":"ATS\/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005","volume":"171","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.anai.2025.01.003_bib0004","first-page":"36","article-title":"Fractional Exhaled Nitric Oxide (FENO) in the management of asthma: a position paper of the Italian Respiratory Society (SIP\/IRS) and Italian Society of Allergy, Asthma and Clinical Immunology (SIAAIC)","volume":"15","author":"Heffler","year":"2020","journal-title":"Multidiscip Respir Med"},{"issue":"1","key":"10.1016\/j.anai.2025.01.003_bib0005","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jaip.2023.08.027","article-title":"The impact of airway obstruction on Feno values in asthma patients","volume":"12","author":"Michils","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"2","key":"10.1016\/j.anai.2025.01.003_bib0006","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.resp.2012.09.011","article-title":"Axial distribution of exhaled nitric oxide production in asthma","volume":"185","author":"Van Muylem","year":"2013","journal-title":"Respir Physiol Neurobiol"},{"issue":"3","key":"10.1016\/j.anai.2025.01.003_bib0007","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.jaci.2013.12.1070","article-title":"Exhaled nitric oxide: a biomarker integrating both lung function and airway inflammation changes","volume":"134","author":"Haccuria","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2025.01.003_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114101","article-title":"Exhaled nitric oxide and its predictive power related to lung function and bronchial inflammation","volume":"179","author":"Van Muylem","year":"2020","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"10.1016\/j.anai.2025.01.003_bib0009","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00392-2017","article-title":"Airway calibre variation is a major determinant of exhaled nitric oxide's ability to capture asthma control","volume":"50","author":"Michils","year":"2017","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.anai.2025.01.003_bib0010","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.jaci.2015.09.054","article-title":"Different patterns of exhaled nitric oxide response to \u03b22-agonists in asthmatic patients according to the site of bronchodilation","volume":"137","author":"Michils","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2025.01.003_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2023.107391","article-title":"Impulse oscillometry defined small airway dysfunction in asthmatic patients with normal spirometry: prevalence, clinical associations, and impact on asthma control","volume":"218","author":"Cottini","year":"2023","journal-title":"Respir Med"},{"key":"10.1016\/j.anai.2025.01.003_bib0012","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.rmed.2016.05.006","article-title":"The prevalence of small airways disease in adult asthma: a systematic literature review","volume":"116","author":"Usmani","year":"2016","journal-title":"Respir Med"},{"issue":"5","key":"10.1016\/j.anai.2025.01.003_bib0013","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/S2213-2600(19)30049-9","article-title":"Exploring the relevance and extent of small airways dysfunction in asthma (ATLANTIS): baseline data from a prospective cohort study [published correction appears in Lancet Respir Med. 2019;7(9):e28]","volume":"7","author":"Postma","year":"2019","journal-title":"Lancet Respir Med"},{"issue":"9","key":"10.1016\/j.anai.2025.01.003_bib0014","article-title":"Small airways: the\u201csilent zone\u201d of 2021 GINA report?","volume":"23","author":"Cottini","year":"2022","journal-title":"Front Med"},{"issue":"1","key":"10.1016\/j.anai.2025.01.003_bib0015","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12948-021-00147-8","article-title":"Small airway dysfunction and poor asthma control: a dangerous liaison","volume":"19","author":"Cottini","year":"2021","journal-title":"Clin Mol Allergy"},{"key":"10.1016\/j.anai.2025.01.003_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2020.106243","article-title":"Prevalence and features of IOS-defined small airway disease across asthma severities","volume":"176","author":"Cottini","year":"2021","journal-title":"Respir Med"},{"issue":"3","key":"10.1016\/j.anai.2025.01.003_bib0017","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.jaip.2019.10.040","article-title":"Clinical characterization and predictors of IOS-defined small-airway dysfunction in asthma","volume":"8","author":"Cottini","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"9","key":"10.1016\/j.anai.2025.01.003_bib0018","doi-asserted-by":"crossref","first-page":"3359","DOI":"10.1016\/j.jaip.2021.04.035","article-title":"Study group. Small airway dysfunction links asthma severity with physical activity and symptom control","volume":"9","author":"Abdo","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.anai.2025.01.003_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2023.107154","article-title":"Small airway dysfunction in asthmatic patients treated with as-needed SABA monotherapy: a perfect storm","volume":"209","author":"Cottini","year":"2023","journal-title":"Respir Med"},{"key":"10.1016\/j.anai.2025.01.003_bib0020","unstructured":"Global Initiative for Asthma. Global strategy for asthma management and prevention. Accessed December 7, 2023. Available at: http:\/\/ginasthma.org\/2023-gina-report-global-strategy-for-asthma-management-and-prevention"},{"issue":"6","key":"10.1016\/j.anai.2025.01.003_bib0021","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1183\/09031936.03.00089403","article-title":"The forced oscillation technique in clinical practice: methodology, recommendations and future developments","volume":"22","author":"Oostveen","year":"2003","journal-title":"Eur Respir J"},{"key":"10.1016\/j.anai.2025.01.003_bib0022","series-title":"ImpulseOscillometry. Analysis of Lung Mechanics in General Practice and the Clinic, Epidemiology and Experimental Research","author":"Vogel","year":"1994"},{"issue":"6","key":"10.1016\/j.anai.2025.01.003_bib0023","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S2213-2600(14)70103-1","article-title":"Unlocking the quiet zone: the small airway asthma phenotype","volume":"2","author":"Lipworth","year":"2014","journal-title":"Lancet Respir Med"},{"issue":"4","key":"10.1016\/j.anai.2025.01.003_bib0024","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1378\/chest.07-0913","article-title":"Distal airway function in symptomatic subjects with normal spirometry following World Trade Center dust exposure","volume":"132","author":"Oppenheimer","year":"2007","journal-title":"Chest"},{"issue":"42","key":"10.1016\/j.anai.2025.01.003_bib0025","doi-asserted-by":"crossref","first-page":"7159","DOI":"10.2174\/0929867327666200713184659","article-title":"An emerging role for exhaled nitric oxide in guiding biological treatment in severe asthma","volume":"27","author":"Rolla","year":"2020","journal-title":"Curr Med Chem"},{"issue":"2","key":"10.1016\/j.anai.2025.01.003_bib0026","doi-asserted-by":"crossref","first-page":"400","DOI":"10.3390\/antiox12020400","article-title":"Exploring the interaction between fractional exhaled nitric oxide and biologic treatment in severe asthma: a systematic review","volume":"12","author":"Pianigiani","year":"2023","journal-title":"Antioxidants (Basel)"},{"issue":"2","key":"10.1016\/j.anai.2025.01.003_bib0027","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.jaip.2021.09.020","article-title":"A low FEV1 confounds interpretation of FeNO as an eligibility criterion for dupilumab","volume":"10","author":"Michils","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"2","key":"10.1016\/j.anai.2025.01.003_bib0028","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1136\/thoraxjnl-2021-217325","article-title":"Derivation of a prototype asthma attack risk scale centred on blood eosinophils and exhaled nitric oxide","volume":"77","author":"Couillard","year":"2022","journal-title":"Thorax"},{"issue":"6","key":"10.1016\/j.anai.2025.01.003_bib0029","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01233-2021","article-title":"Fraction of exhaled nitric oxide is associated with disease burden in the German Asthma Net severe asthma cohort","volume":"59","author":"Bal","year":"2022","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.anai.2025.01.003_bib0030","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.anai.2012.06.022","article-title":"Are we overlooking persistent small airways dysfunction in community-managed asthma?","volume":"109","author":"Anderson","year":"2012","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"3","key":"10.1016\/j.anai.2025.01.003_bib0031","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.jaip.2017.07.032","article-title":"Extrafine versus fine inhaled corticosteroids in relation to asthma control: a systematic review and meta-analysis of observational real-life studies","volume":"6","author":"Sonnappa","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"4","key":"10.1016\/j.anai.2025.01.003_bib0032","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1152\/japplphysiol.00643.2020","article-title":"Exploring the sites and kinetics of bronchodilator response to \u03b2-2 agonists in asthma","volume":"130","author":"Demey","year":"2021","journal-title":"J Appl Physiol (1985)"}],"container-title":["Annals of Allergy, Asthma & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120625000043?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120625000043?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T15:23:43Z","timestamp":1747149823000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1081120625000043"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S1081120625000043"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2025.01.003","relation":{},"ISSN":["1081-1206"],"issn-type":[{"value":"1081-1206","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Small airway dysfunction mediates the relationship between Fractional Exhaled Nitric Oxide and asthma control","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2025.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}